Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00516919 · ClinicalTrials.gov registry record · Phase 4
Study of Behavioral Weight Loss Therapy for Obesity and Binge Eating in Monolingual Hispanic Persons
A Phase 4 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 4
- Development phase
- 79
- Enrollment target
NCT00516919 is a Phase 4 study that has completed, run by Yale University. The registered enrollment target is 79 participants.
The verdict
NCT00516919, a Phase 4 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 79 participants
- Enrollment target
Study Summary
This is a research study designed to examine the effectiveness of an obesity medication (orlistat) given in addition to behavioral weight loss therapy. Participants will be obese monolingual (Spanish-speaking only) men and women.
Interventions
- DRUG Xenical + behavioral intervention
- BEHAVIORAL Behavioral intervention + placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2007-08 |
| Est. Completion | 2010-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00516919
The ClinicalTrials.gov registry entry for NCT00516919 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Xenical + behavioral intervention is the first listed.
NCT00516919 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00516919 about?
NCT00516919 is a clinical study titled "Study of Behavioral Weight Loss Therapy for Obesity and Binge Eating in Monolingual Hispanic Persons". This is a research study designed to examine the effectiveness of an obesity medication (orlistat) given in addition to behavioral weight loss therapy. Participants will be obese monolingual (Spanish-speaking only) men and women.
What is the current status of trial NCT00516919?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 79 participants. The study started on 2007-08. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00516919?
The interventions under investigation include: Xenical + behavioral intervention (DRUG), Behavioral intervention + placebo (BEHAVIORAL).
Who is sponsoring clinical trial NCT00516919?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.